Cite

HARVARD Citation

    Halabi, A. et al. (n.d.). Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment. Clinical pharmacology in drug development. 3 (4), pp. 290-296. [Online]. 
  
Back to record